rheumatologyadvisor13h
Secukinumab vs Adalimumab More Effective for Skin Symptoms in PsA
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.
rheumatologyadvisor13h
Health Literacy-Informed Digital Intervention Reduces Obesity at Age 2 Years
A health literacy-informed digital intervention reduces the incidence of obesity at 24 months of age. HealthDay News — A health literacy-informed digital intervention reduces the incidence of obesity ...
rheumatologyadvisor12h
COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease
HealthDay News — COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.
rheumatologyadvisor13h
Calcium Levels Decrease Less With Each Subsequent Denosumab Dose in Advanced CKD
Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.
rheumatologyadvisor1d
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually ...
rheumatologyadvisor2d
Body Weight Associated With Initial Response to Subcutaneous Tocilizumab in RA
No significant relationship was identified between body weight and the persistence of either intravenous or subcutaneous tocilizumab among patients with rheumatoid arthritis. Body weight may influence ...
rheumatologyadvisor2d
High Resting Heart Rate Tied to Increased Risk for Atrial Fibrillation
Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) in Black adults. HealthDay News — Elevated baseline resting heart rate (RHR) is ...
rheumatologyadvisor6d
Emrosi Approved to Treat Inflammatory Lesions of Rosacea
The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...
rheumatologyadvisor5d
National Diabetes Month: The History and Impact
When was the first National Diabetes Month and how has diabetes research evolved over the years? November is National Diabetes Month, dedicated to increasing awareness and education on how diabetes ...
rheumatologyadvisor6d
JAK Inhibitors Show Superior Pain Reduction in Rheumatoid Arthritis
Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.
rheumatologyadvisor6d
Methotrexate May Help Prevent RA Development Among High-Risk Patients
A 1-year course of methotrexate may help prevent the development of ACPA-negative RA among patients with clinically suspect arthralgia at high-risk for the disease.
rheumatologyadvisor4d
Pain Management Is Holistic Care Beyond ‘Procedures,’ Pain Specialists Contend
Pain medicine should be holistic, with a focus on providing pain relief and an improved quality of life, rather than just about performing procedures.